SCHEMBL14769037

SCHEMBL14769037

COC(=O)c1ccc(NC=O)cc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNASE1L3 Q13609 1/20 0.56
▸ PRMT1 Q99873 1/20 0.56
▸ USP2 O75604 4/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ATM Q13315 2/20 0.50
▸ PLEC Q15149 1/20 0.50
▸ ALPL P05186 1/20 0.48
▸ ALPI P09923 1/20 0.48
▸ ALPG P10696 1/20 0.48
▸ CA9 Q16790 13/20 0.47
▸ CA1 P00915 12/20 0.47
▸ CA2 P00918 12/20 0.47
▸ CA12 O43570 6/20 0.47
▸ ABCB1 P08183 1/20 0.46
▸ PTGER3 P43115 1/20 0.45
▸ CFTR P13569 1/20 0.45
▸ PAX8 Q06710 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13052197 0.86 USP2 (0.59) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL15502054 0.85 DNASE1L3 (0.53) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL13052196 0.85 USP2 (0.56) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL14769031 0.85 USP2 (0.52) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL12192035 0.84 USP2 (0.69) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL14771584 0.84 USP2 (0.52) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL14771585 0.83 USP2 (0.59) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL12295575 0.83 USP2 (0.63) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL14771619 0.83 USP2 (0.56) DNASE1L3PRMT1USP2L3MBTL1MEN1
SCHEMBL31344171 0.82 USP2 (0.60) DNASE1L3PRMT1USP2L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051597-B2 Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme MITSUBISHI RAYON CO., LTD. (JP) 2015-06-09 — — US disclosed
US-20140072990-A1 FLUORESCENT SUBSTRATE FOR DETECTION OF ENZYMATIC ACTIVITY OF NITRILE-RELATED ENZYME THE UNIVERSITY OF TOKYO (JP) 2014-03-13 — — US disclosed
US-20130065263-A1 FLUORESCENT SUBSTRATE FOR DETECTION OF ENZYMATIC ACTIVITY OF NITRILE-RELATED ENZYME THE UNIVERSITY OF TOKYO (JP) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065263-A1 FLUORESCENT SUBSTRATE FOR DETECTION OF ENZYMATIC ACTIVITY OF NITRILE-RELATED ENZYME DNPH1, NOS1, NAALAD2 DNASE1L3 613/4885PRMT1 244/4885USP2 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback